Overview
Acceleration program for high-growth early-stage tech startups.
Founded
2020
Deals · 12mo
8
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Magnar | Sep 2026Participated | $8 MSeries A | |
50X | Sep 2026Led | $0.55 MOther Equity | |
Fina | Aug 2026Participated | $1 MSeed | |
Kapso | Aug 2026Participated | $1 MOther Equity | |
Magnar | Jul 2026Participated | $0.80 MSeed | |
Ray Therapeutics | Apr 2026Participated | $125 MSeries B | |
Poplar Therapeutics | Jan 2026Led | $50 MSeries A | |
Grupalia | Dec 2025Participated | $5 MSeed | |
Finture | Sep 2025Participated | $32 MSeries C | |
Soyio | Apr 2025Participated | $1 MSeed | |
Callio Therapeutics | Mar 2025Participated | $187 MSeries A | |
Nuvig Therapeutics | Dec 2024Participated | $161 MSeries B | |
Magnar | Sep 2026Participated | $8 MSeries A | |
50X | Sep 2026Led | $0.55 MOther Equity | |
Fina | Aug 2026Participated | $1 MSeed | |
Kapso | Aug 2026Participated | $1 MOther Equity | |
Magnar | Jul 2026Participated | $0.80 MSeed | |
Ray Therapeutics | Apr 2026Participated | $125 MSeries B | |
Poplar Therapeutics | Jan 2026Led | $50 MSeries A | |
Grupalia | Dec 2025Participated | $5 MSeed | |
Finture | Sep 2025Participated | $32 MSeries C | |
Soyio | Apr 2025Participated | $1 MSeed | |
Callio Therapeutics | Mar 2025Participated | $187 MSeries A | |
Nuvig Therapeutics | Dec 2024Participated | $161 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 5 |
| Series A | 2 | 4 |
| Series B | 0 | 2 |
| Series C+ | 0 | 1 |
| Other Equity | 2 | 5 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '22 | 1 |
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 1 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 2 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 1 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 1 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 1 |
| Aug '26 | 2 |
| Sep '26 | 2 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 8 |
| Enterprise Software | 6 |
| Fintech | 5 |
| Professional Services | 5 |
| Networks, Cloud & Communication | 3 |
| Crypto & Blockchain | 2 |
| AI & Machine Learning | 2 |
| Developer Tools | 2 |
| Cybersecurity & Privacy | 1 |
| E-Commerce & Retail | 1 |
| Clean Energy & Sustainability | 1 |
| Transportation & Logistics | 1 |
| Hardware & Robotics | 1 |
| Social & Community Platforms | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 10 |
| $5M-$10M | 2 |
| $10M-$25M | 0 |
| $25M-$50M | 3 |
| $50M-$100M | 2 |
| $100M-$250M | 4 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 8 of 8 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 9 |
| Chile | 5 |
| Mexico | 2 |
| Singapore | 1 |
| Brazil | 1 |
| Venezuela | 1 |
| China | 1 |
| Guatemala | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Novo Holdings | 5 |
| Norwest Venture Partners | 4 |
| 4BIO Capital | 2 |
| Bristol Myers Squibb | 2 |
| Deerfield Management | 2 |
| Devlabs | 2 |
| Digitalis Ventures | 2 |
| Fen Ventures | 2 |
| Mission BioCapital | 2 |
| MRL Ventures Fund | 2 |
| Norte Ventures | 2 |
| Semilla Ventures | 2 |
| 500 Global | 1 |
| 6 Degrees Capital | 1 |
| 99 Startups | 1 |
| abrdn | 1 |
| Adage Capital Management | 1 |
| Alexandria Venture Investments | 1 |
| ARCH Venture Partners | 1 |
| B Capital Group | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 19% |
| Participating | 17 | 81% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 25% |
| Co-led | 3 | 75% |
Team
Partner
PV 21-2
PV 20-1 batch
Partner
Partner
PV 22-1
Partner
PV Gen 21-2